Low
₹461.60
High
₹480.80
| Previous Close | ₹463.10 |
|---|---|
| Day's Range | ₹461.60 - ₹480.80 |
| Open | ₹480.80 |
| 52 Week Range | ₹403.35 - ₹577.00 |
| Volume | 24,95,630 |
| Market Cap | ₹0.08 |
| Trade Value ( ₹ in Lacs) | 11,663.51 |
|---|---|
| Market Cap (₹ in Mn) | 0.08 |
| Dividend Yield(%) | 1.78 |
| Price/Earning (TTM) | 43.34 |
| TTM EPS (₹) | 10.68 |
| P/E Ratio | 50.79 |
| Book Value(₹) | 7.19 |
| PAT Margin (%) | 11.98 |
| Face Value (₹) | 1.00 |
| ROCE(%) | 21.47 |
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 28301.4 | 90707.1 |
| Expenses | N/A | N/A |
| PBT | 4119.1 | 18083.4 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 3127.3 | 14032.2 |
| Founded | 1975 |
|---|---|
| NSE Symbol | DABUR |
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Hindustan Unilever Ltd. | 5,32,828.56 | 2,267.75 | 2,022.50 - 2,022.50 |
| ITC Ltd. | 3,81,334.37 | 304.35 | 287.00 - 287.00 |
| Nestle India Ltd. | 2,83,182.60 | 1,473.75 | 1,084.70 - 1,084.70 |
| Varun Beverages Ltd. | 1,65,309.72 | 490.00 | 381.00 - 381.00 |
| Britannia Industries Ltd. | 1,28,539.37 | 5,336.50 | 5,298.00 - 5,298.00 |
| Marico Ltd. | 1,08,174.70 | 835.00 | 680.30 - 680.30 |
| Godrej Consumer Products Ltd. | 1,05,557.91 | 1,031.60 | 967.05 - 967.05 |
| Dabur India Ltd. | 82,130.72 | 463.05 | 403.35 - 403.35 |
| Colgate-Palmolive (India) Ltd. | 58,025.42 | 2,130.00 | 1,782.00 - 1,782.00 |
| Patanjali Foods Ltd. | 48,709.18 | 445.10 | 438.00 - 438.00 |
No Records Found
Further to letter dated April 17, 2026 and pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Dabur India has informed that it enclosed the link of webcast of the Investors’ Conference call scheduled on May 7, 2026 at 5.00 pm IST (due to some technical issue in the link shared earlier vide its aforesaid letter dated April 17, 2026) to be held post declaration of Financial Results for the quarter and financial year ended on March 31, 2026. The Investors` Conference Call details along with updated link of the webcast of the conference call is also enclosed. Diamond Pass for Registration of conference call: Link for Diamond Pass Registration One way audio webcast of the Conference Call will be hosted on the Company’s website (Link).
The above information is a part of company’s filings submitted to BSE.
In furtherance to its intimations dated April 01, 2026, March 31, 2026, March 30, 2026, March 13, 2026, December 05, 2025 and May 26, 2025 regarding the proposed Scheme of Amalgamation between Sesa Care (‘Transferor Company’) and the Company (‘Transferee Company’) and their respective shareholders and creditors under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 (‘Act’) read with rules made thereunder (‘Scheme’), Dabur India has informed that it enclosed the summary of proceedings of the meetings of the equity shareholders and unsecured creditors of the Company held on May 02, 2026: 1. Proceedings of the equity shareholders of the Company as Annexure-1; and 2. Proceedings of the unsecured creditors of the Company as Annexure - II.
The above information is a part of company’s filings submitted to BSE.
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Dabur India has informed that the Board of Directors of the Company on Monday April 27, 2026 have: i) noted resignation of Isha Lamba, Head-Investor Relations & M&A, in the category of Senior Management Personnel of the Company, with effect from the close of business hours of May 01, 2026. ii) Upon recommendation of the Nomination & Remuneration Committee, approved the appointment of Rahul Sarawagi as ‘Additional General Manager - IR & M&A’ in the category of Senior Management Personnel of the Company with effect from April 28, 2026. Pursuant to provisions of Regulation 30 of the Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 issued on July 11, 2023 (last updated on January 30, 2026), requisite disclosures with respect to aforementioned resignation and appointment is attached as Annexure A. Further, copy of the resignation letter/email is enclosed as Annexure B. The above information shall also be made available on the Company's website at www.dabur.com.
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Dabur India has submitted an update on its previous disclosure dated February 17, 2026 regarding appointment of Herjit S. Bhalla as the ‘Chief Executive Officer - India Business’ in the category of Senior Management Personnel of the Company with effect from April 15, 2026 or such other date as may be agreed between the Company and Bhalla. With respect to the above, the company has informed that Herjit S. Bhalla has joined the Company as ‘Chief Executive Officer- India Business’ in the category of Senior Management Personnel of the Company with effect from Thursday, April 23, 2026. He shall report to Mohit Malhotra, Whole-time Director and Global Chief Executive Officer of the Company. The above information shall also be made available on the Company's website at www.dabur.com.
No Records Found
The current share price of Dabur India Ltd. is ₹463.10 as of 2026-05-13.
The market capitalisation of Dabur India Ltd. is ₹82,130.72 as of 2026-05-13.
The 1-year return of Dabur India Ltd. is 0.00% as of 2026-05-13.
The P/E ratio of Dabur India Ltd. is 50.79 as of 2026-05-14.
The 52-week high and low of Dabur India Ltd. are ₹577.00 and ₹403.35, respectively, as of 2026-05-13.
Dabur India Ltd. markets Ayurvedic and natural healthcare, personal care, home care, foods and beverages including Dabur Chyawanprash, Real juices and Dabur Amla oil.
Dabur India Ltd. serves rural and urban markets through a large distribution network, village‑level initiatives and strong presence in kirana, modern trade and e‑commerce.
Dabur India Ltd.’s portfolio includes health supplements, digestives, OTC and Ayurvedic medicines, hair care, oral care, skin care, juices and home‑care products.
Dabur India Ltd. leverages its Ayurvedic heritage, mass advertising campaigns and category leadership in natural health and personal care to stay visible.
Dabur India Ltd. uses super‑stockists, distributors, rural sub‑stockists, modern trade tie‑ups and online marketplaces for nationwide product availability.
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.